Tonix stock price forecast suggests cautious accumulation

Tonix stock price forecast suggests cautious accumulation strategies, as institutional inflow reports show marginal increases from Q2 levels. "We are now in the realm of VIX levels that demand a policy response if stocks are to stabilize," wrote Nicholas Colas, Co-founder of DataTrek Research, in a Wednesday morning analysis. "We need to see the VIX at 80 (2008, 2020 peaks) or at least 62 (March 2020 bottom for the S&P 500) before thinking of calling a near term low for U.S. large caps," Colas added. As the FDA decision looms, opinions on X remain divided, with some expressing optimism about potential approval and others cautioning about the challenges of execution and sales post-approval. There’s a notable focus on the company’s financial stability, with its reported cash reserves seen as a positive factor by some. The conversation continues to evolve, keeping the spotlight on TNXP as a stock to watch. Tonix stock price forecast reflects near-term unpredictability as RSI levels hover near overbought territory, hinting at possible corrective pullbacks.